ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Letter To The Editor: Prevention Research Requires Rigor And Collaboration.

June 20, 2003

Clinical Trials, Centers Would Be First In Line For Money Added To Budget, Broder Tells Congress

March 31, 1989

NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer

November 20, 1998

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

High-Starch Diet May Raise Risk Of Pancreatic Cancer

October 25, 2002